FGFR2 and neoplasm: In addition, the finding that SCFAs attenuate Ras signaling in vivo, in part, by up-regulating the expression of human disabled 2 (DAB2), a tumor suppressor of the Ras and Wnt pathways [39], suggests that SCFAs may also impact FGFR2 and Hippo signaling in tumor development.